GaryJosephRomanoMD
Neurology • Philadelphia, PANeurophysiology
Affiliate Faculty, Drexel University School of Medicine
Are you Dr. Romano?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 51 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3509 N Broad St
Philadelphia, PA 19140Phone+1 215-707-3040Fax+1 215-707-8235
Summary
- Dr. Gary Romano, MD is a board certified neurologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Temple University Hospital and Hahnemann University Hospital.
Education & Training
University of Pennsylvania Health SystemResidency, Neurology, 1993 - 1997
Johns Hopkins University School of MedicineClass of 1992
Certifications & Licensure
PA State Medical License 1993 - 2024- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 1 citationsImmediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial.Joshua D Grill, Rema Raman, Karin Ernstrom, Shunran Wang, Michael C Donohue
Neurology. Clinical Practice. 2024-04-01 - 1 citationsGenome-wide association study of abnormal elevation of ALT in patients exposed to atabecestat.Qingqin S Li, Stephan Francke, Jan Snoeys, John Thipphawong, Gary Romano
BMC Genomics. 2023-09-01 - 75 citationsFindings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial.Reisa A. Sperling, David B. Henley, Paul S. Aisen, Rema Raman, Michael C. Donohue
JAMA Neurology. 2021-03-01
Press Mentions
In the Lead-up to Rare Disease Day, CENTOGENE Expands Observational Study to Advance the Genetic Understanding of Frontotemporal Dementia (FTD)February 21st, 2023- AL101 Safely Increases Progranulin Levels in Phase 1 TrialDecember 2nd, 2022
- Alector : Announces Appointment of Gary Romano, M.D., Ph.D., as Chief Medical Officer - Form 8-KMarch 29th, 2022
- Join now to see all
